A biopsy confirms cancer and its type. Molecular testing goes a step further, reading the tumour’s genes and proteins to understand what’s actually driving it. That detail matters because two cancers that look identical under a microscope can behave completely differently, and respond to completely different drugs. The test is what reveals which one you’re dealing with.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “The biopsy tells us it’s cancer and what kind. Molecular testing tells us how it ticks. We’re looking for specific mutations, the ones a targeted drug can switch off. Without that information you’re treating blind. With it, you can sometimes skip the heavy chemotherapy entirely and hit the exact fault driving the tumour. That’s the whole shift in modern oncology.”

It digs into the tumour’s biology, looking for the specific faults that drive it.

• Driver mutations : Certain genes, when faulty, push a cancer to grow. Testing finds them, and many now have a drug built to target them.
• Receptors : Breast and other cancers are checked for hormone receptors and HER2. Those results decide whole categories of treatment.
• Immunotherapy markers : Some tumours carry signals, like PD-L1, that predict whether immunotherapy will work. Testing flags them upfront.
• Resistance clues : The profile can hint at which drugs a tumour will shrug off, saving the patient from a treatment that won’t work.

This is the information that decides whether robotic cancer surgery alone is enough or whether targeted drugs need to join the plan.

The results don’t just describe the cancer. They actively redirect how it’s treated.

• Targeted therapy : Find a driver mutation with a matching drug, and treatment can hit that exact fault. Far more precise than blanket chemotherapy.
• Sparing chemo : Sometimes the profile shows a targeted drug will outperform chemotherapy. The patient avoids the harsher option altogether.
• Sequencing the plan : The results help decide what comes first, surgery, drugs, or a combination. Order matters, and this informs it.
• A clearer prognosis : The molecular picture often refines the outlook, giving patient and doctor a more honest sense of what lies ahead.

All of this builds on what your biopsy report first reveals, taking that same tissue sample and extracting far more from it.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. His diagnostic approach treats molecular testing as a core step, not an afterthought, so treatment is built on the tumour’s actual biology rather than its appearance alone. Every result goes through tumour board review, where surgeons and oncologists read the molecular picture together. That integration is what turns a test result into the right plan.

Molecular detail is where modern cancer care separates itself from the old one size fits all approach. The same diagnosis can need very different treatment depending on what the genes show. Reading that correctly, and acting on it, is what lets a patient get the precise therapy their cancer responds to. Used well, it means better outcomes with less unnecessary treatment.

References

1. Molecular profiling of advanced malignancies — National Library of Medicine
2. Molecular genetic testing and targeted therapy — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Air pollution is a proven cause of lung cancer, and India’s pollution levels make that a real concern. It isn’t only a smoker’s disease anymore. The tiny particles in polluted air, especially PM2.5, get deep into the lungs and damage cells over years. In cities where the air stays toxic for months, that exposure adds up to a genuine cancer risk.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “We’re seeing lung cancer in people who never touched a cigarette, and pollution is a big part of why. The fine particles in dirty air carry carcinogens straight into the lungs. Breathe that in day after day for years and the risk is real. In our most polluted cities, the air itself has become a risk factor we can’t ignore.”

The damage comes from what’s actually floating in the air and how deep it travels.

• PM2.5 particles : These are small enough to reach the deepest parts of the lung. Once there, they lodge and irritate tissue for years.
• Carcinogens onboard : Polluted air carries known cancer causing chemicals, from vehicle exhaust to industrial output. The particles ferry them right in.
• Chronic inflammation : Constant exposure keeps the lungs inflamed. That ongoing irritation is the kind of slow damage that lets cancer take hold.
• Years of exposure : It’s not one bad day. It’s breathing polluted air daily over years that builds the risk, quietly and steadily.

This is why pollution sits alongside other causes, and proper lung cancer treatment increasingly sees patients with no smoking history at all.

Pollution related lung cancer doesn’t hit everyone equally. Some are far more exposed.

• City dwellers : People in high pollution cities breathe far more PM2.5 than rural populations. The long term exposure is simply higher.
• Non smokers too : You don’t have to smoke to be at risk. A rising share of lung cancers now appear in lifelong non smokers.
• Indoor smoke : Biomass cooking fuels and indoor smoke add their own load, hitting women in many Indian households particularly hard.
• Outdoor workers : Traffic police, street vendors, construction workers. Anyone spending long hours in polluted air carries a heavier exposure.

Pollution and tobacco often work together, which is why understanding smoking and lung cancer completes the picture of what’s driving the disease in India.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats lung cancer across the spectrum, including the growing group of non smoking patients whose disease is driven by pollution and other factors. The approach starts with not assuming, since a non smoker with a lung mass deserves the same careful workup as anyone else. That openness is what catches these cancers in people who’d never expect them.

The shift matters clinically. Lung cancer in non smokers often behaves differently and carries different mutations, which changes how it’s treated. Recognising that a patient’s cancer may be pollution linked rather than smoking linked shapes the whole plan. Minimally invasive surgery like VATS, in experienced hands, then offers these patients a recovery that fits the early stage many of them are caught at.

References

1. Air pollution and lung cancer in never smokers — National Library of Medicine
2. Risk factors for lung cancer among never smokers — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Enhanced Recovery After Surgery, usually shortened to ERAS, is a set of evidence based steps that help patients recover faster after major surgery. It isn’t one treatment. It’s a whole pathway, covering the days before, during and after the operation. The aim is simple: less stress on the body, fewer complications, and home sooner. It’s now standard for major cancer operations.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “ERAS changed how we think about recovery. The old way kept patients fasting for ages and flat in bed for days. We now know that’s actually worse. Letting people eat sooner, walk the same day, and managing pain without leaning on heavy opioids, all of it helps the body bounce back. The science behind each step is solid.”

It’s a coordinated set of steps across the whole surgical journey, each one backed by evidence.

• Before surgery : Proper counselling, good nutrition and shorter fasting. Some patients even get a carbohydrate drink before, which eases the stress of surgery.
• Smarter pain control : Pain is managed with a mix of methods that lean away from heavy opioids. Less grogginess, fewer side effects, quicker movement.
• Early eating : Food returns within hours, not days. The gut wakes up faster when it’s used, and that speeds the whole recovery along.
• Early walking : Getting up the same day matters more than people expect. It cuts clot risk, helps the lungs and gets the body moving again.

These principles work hand in hand with minimally invasive techniques, and robotic cancer surgery makes the smaller incisions that let ERAS deliver its full benefit.

ERAS works because it treats recovery as something to actively manage, not just wait out.

• Less surgical stress : Every step is designed to reduce the body’s stress response to surgery. Lower stress means a faster, smoother recovery.
• Fewer complications : Early movement and eating cut the rate of chest infections, clots and gut problems. The data on this is consistent.
• Shorter stays : Patients go home days earlier than with old style care. That’s not rushing them, it’s that they’re genuinely ready sooner.
• Better cancer care : Recovering faster means starting any needed chemotherapy sooner. For cancer patients, that timing genuinely matters.

It pairs perfectly with laparoscopic cancer surgery, where the smaller incisions and faster healing amplify everything ERAS is trying to achieve.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. His practice combines minimally invasive surgery with structured recovery pathways, so patients heal faster and with fewer setbacks. The whole approach is built around reducing the toll surgery takes, since a smoother recovery isn’t a luxury, it’s part of good cancer care.

Recovery is where minimally invasive surgery and ERAS reinforce each other. Smaller incisions mean less pain and trauma, which makes early eating and walking far easier to achieve. Patients spend less time in hospital, face fewer complications, and get back to their lives, and any further treatment, sooner. That combination is what modern surgical recovery is built on.

References

1. ERAS protocol in colorectal cancer resections — National Library of Medicine
2. Enhanced recovery after surgery systematic review — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Organ-sparing cancer surgery removes the tumour while keeping as much of the organ, and its function, as safely possible. The older approach often meant taking the whole organ to be sure. This one aims narrower: clear the cancer, save the rest. It only works when the tumour’s size, location and stage allow it, but when they do, the difference to a patient’s life is real.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “The goal has shifted. We used to remove the whole organ to be certain the cancer was gone. Now, in the right cases, we can take the tumour with a clear margin and leave the function intact. A breast, a working sphincter, a kidney. But it’s never function over cure. The cancer control has to be equal first. Only then does preservation come in.”

The principle is precision: take exactly what’s diseased and protect what isn’t.

• Clear margins first : The tumour comes out with a rim of healthy tissue around it. That clearance is non negotiable, function comes after.
• Sparing the rest : Surrounding nerves, muscle and healthy organ tissue are carefully preserved. What stays is what keeps the organ working.
• Right patient : It isn’t for everyone. Tumour size, position and stage decide whether sparing is safe or whether full removal is wiser.
• Better tools help : Robotic and minimally invasive techniques make the fine dissection possible, getting close to structures without damaging them.

This kind of precision is the backbone of modern robotic cancer surgery, where the technology exists specifically to spare what doesn’t need removing.

Organ-sparing approaches now exist across many cancer types, each with its own version.

• Breast : Breast conserving surgery removes the lump, not the whole breast. For early disease, outcomes match mastectomy with far less loss.
• Rectum : Sphincter preserving surgery lets many patients avoid a permanent stoma. The bowel keeps working the way it should.
• Kidney : Partial nephrectomy takes the tumour and leaves the rest of the kidney. Preserving kidney function matters enormously long term.
• Testis and bladder : Selected cases allow part of the organ to be saved, protecting fertility, hormones or urinary function where possible.

A clear example is avoiding a permanent stoma in rectal cancer, where preserving the sphincter changes daily life entirely.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. His work centres on removing cancer completely while preserving function wherever the tumour allows, across breast, colorectal, kidney and other cancers. The approach always puts cancer control first, then asks how much can safely be saved. That order is what makes organ preservation responsible rather than risky.

Organ sparing only works in skilled, high volume hands. Judging exactly how much can be safely preserved, and executing that dissection precisely, takes experience built over years. Done well, it means a patient beats their cancer and keeps a breast, a kidney or normal bowel function. That balance, full cure with minimal loss, is the whole point of modern surgical oncology.

References

1. Organ preservation in cancer surgery review — National Library of Medicine
2. Organ preservation for rectal cancer — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Intraoperative ultrasound is imaging done live, during the operation itself. The surgeon places an ultrasound probe directly on the organ to see inside it in real time. It shows tumours, blood vessels and structures that scans before surgery can’t fully map. The point is simple: see exactly what’s there, right when it matters most.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Scans done before surgery are a plan, not a live map. Once we’re operating, things shift, and a small tumour deep in the liver can be impossible to feel. Intraoperative ultrasound lets us look inside the organ as we work. It finds what the hands can’t, and it keeps us off the vessels we need to protect.”

A probe goes straight onto the organ, and the surgeon reads the picture as the operation unfolds.

• Direct contact : The sterile probe touches the organ itself, not the skin. That closeness gives far sharper images than a scan from outside.
• Real time : The picture updates live as the surgeon moves. No waiting, no guessing from an image taken hours earlier.
• No radiation : It uses sound waves, not X-rays. So it can be used freely during surgery without any radiation worry for anyone in the room.
• Finds the hidden : A small tumour buried deep in tissue, invisible and impossible to feel, shows up clearly on the screen.

This kind of precision underpins modern robotic cancer surgery, where seeing inside the organ in real time changes what the surgeon can safely do.

Some operations lean on intraoperative ultrasound far more than others, usually where tumours hide.

• Liver surgery : The biggest user. The liver hides tumours deep in its substance, and the probe finds every one before the surgeon cuts.
• Pancreas : Small tumours and the vessels around them are mapped precisely, which matters enormously in such a delicate area.
• Brain : Surgeons use it to locate tumours and judge how much has been removed, all without moving the patient for a scan.
• Protecting margins : By showing the tumour edge in real time, it helps the surgeon take enough tissue without taking too much.

This is exactly how a clean surgical margin gets achieved in practice, by seeing the tumour boundary rather than estimating it.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He uses real time imaging tools like intraoperative ultrasound where they genuinely improve precision, particularly in liver and complex abdominal cancer surgery. The approach is built on seeing clearly before cutting, since a tumour you can locate exactly is one you can remove completely. That clarity is what separates a good resection from an incomplete one.

Precision tools only matter in trained hands. Reading an ultrasound image mid surgery and acting on it instantly takes experience that comes from volume. Used well, it means smaller margins of error, better protection of healthy tissue, and a cleaner removal of the cancer. That combination of skill and the right technology is what drives a good surgical outcome.

References

1. Intraoperative ultrasound applications and value — National Library of Medicine
2. Intraoperative ultrasound implementation guide — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Cancer vaccines do exist in India, and they’re already in everyday use. The catch is what kind. The ones available now are preventive, they stop the infections that lead to certain cancers, rather than treating cancer that’s already there. The HPV vaccine and the Hepatitis B vaccine are the two big examples, both widely available.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “People hear cancer vaccine and picture a shot that cures cancer. That’s not what these are, at least not yet. The HPV and Hepatitis B vaccines prevent the viral infections that cause cervical and liver cancer. They work brilliantly, but only before exposure. The vaccines that treat existing cancer are still mostly in trials.”

India has preventive vaccines that genuinely stop certain cancers from ever starting.

• HPV vaccine : Prevents the high risk HPV strains behind most cervical cancer. Given to girls before exposure, it’s a true cancer preventer.
• CERVAVAC : India’s own HPV vaccine, made by the Serum Institute. Affordable and indigenous, it’s now part of a national rollout.
• Hepatitis B vaccine : Long part of routine immunisation. By preventing chronic Hepatitis B, it cuts the risk of liver cancer down the line.
• The catch : All of these are preventive. They work before the infection takes hold, which is why timing and age matter so much.

This is why prevention starts young, and proper cervical cancer treatment becomes far less likely in populations where HPV coverage is high.

This is where the science is moving fast, but the everyday reality lags behind.

• Therapeutic vaccines : These aim to train the immune system to attack an existing tumour. Different goal entirely from prevention.
• Still in trials : Most therapeutic cancer vaccines remain investigational worldwide. Promising results, but not yet routine care.
• Personalised approaches : Some newer vaccines are built around a patient’s own tumour mutations. Cutting edge, but far from widely available.
• The honest position : For now, treating cancer still rests on surgery, chemotherapy, radiation and immunotherapy. Vaccines treating cancer are coming, not here.

Prevention remains the proven path, which is why the HPV vaccine matters so much as a tool that stops cancer at the source.

Dr. Sandeep Nayak is a surgical oncologist with 24 years behind him and a fellowship in laparoscopic and robotic onco-surgery. He treats HPV related cancers, including cervical and head and neck disease, where prevention and early detection shape outcomes long before surgery enters the picture. The approach starts with separating what vaccines can actually do from the hype, since clear information is what lets families make sound decisions.

The distinction matters more than people realise. A preventive vaccine given at the right age can stop a cancer that would otherwise need major surgery years later. That’s a genuine win. Understanding which vaccines exist, what they do, and when they work is part of giving patients an honest, complete picture of their options.

References

1. HPV vaccination and cervical cancer in India — National Library of Medicine
2. Cervical cancer prevention overview — National Cancer Institute

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.